Thus , adjunctive radiotherapy is beneficial for Stage I cervical cancer patients with clinical-pathological risk factors for recurrence other than positive nodes .
In 1988 the GOG initiated a prospective randomized study (GOG #92) , reported here , to investigate the benefits and risks of adjuvant radiotherapy for Stage I cervical cancer patients treated by conventional radical hysterectomy and pelvic lymphadenectomy and who were at high risk for recurrence , because of LTD , DSI , CLS , but excluding patients with lymph node metastases .
